# Rose of Jericho (Anastatica hierochuntica)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/rose-of-jericho-anastatica-hierochuntica
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-02
**Evidence Score:** 1 / 10
**Category:** Middle Eastern
**Also Known As:** Anastatica hierochuntica L., Rose of Jericho, Resurrection Plant, Kaff Maryam, Hand of Mary, Jericho Rose, True Rose of Jericho, Resurrection Flower

## Overview

Anastatica hierochuntica contains flavonoids — principally rutin, quercetin, luteolin, and the unique anastatin A and B — that exert antioxidant, [hepatoprotective](/ingredients/condition/detox), antibacterial, and xanthine oxidase-inhibitory effects through [free radical scaveng](/ingredients/condition/antioxidant)ing and enzyme modulation. In preclinical studies, ethanolic extracts achieved antioxidant IC₅₀ values as low as 0.016 mg/mL, anastatin A and B surpassed the hepatoprotective standard silybin in mouse hepatocyte assays, and rutin inhibited xanthine oxidase with an IC₅₀ of 11.35 µM.

## Health Benefits

- **[Hepatoprotective](/ingredients/condition/detox) Activity**: Anastatin A and B, benzofuran-moiety flavonoids isolated from methanolic extracts, demonstrated hepatoprotective effects against chemically induced mouse hepatocyte damage at potency exceeding the reference drug silybin, suggesting meaningful liver-protective potential.
- **Antioxidant and [Free Radical Scaveng](/ingredients/condition/antioxidant)ing**: Polar and non-polar phenolic fractions, including quercetin, luteolin, and rutin, produced strong antioxidant activity in vitro, with ethanol extract IC₅₀ values of 0.016 ± 0.001 mg/mL, indicating highly potent radical scavenging capacity relative to concentration.
- **Anti-Diabetic Properties**: Traditional use across Middle Eastern medicine systems attributes blood-glucose-modulating effects to the plant; the flavonoid-rich fractions are hypothesized to inhibit α-glucosidase and reduce oxidative stress associated with hyperglycemia, though direct clinical evidence remains limited.
- **Antibacterial Activity**: Acetone extracts produced measurable inhibition zones against gram-positive Bacillus subtilis (75% inhibition, MDIZ 20.31 mm) and Staphylococcus aureus (72% inhibition, MDIZ 27.19 mm), and gram-negative Escherichia coli (83% inhibition, MDIZ 20.15 mm), supporting broad-spectrum [antimicrobial](/ingredients/condition/immune-support) utility.
- **Anti-Hyperuricemic Potential**: Rutin and quercetin from the plant inhibited xanthine oxidase — the enzyme responsible for uric acid overproduction in gout — with IC₅₀ values of 11.35 µM and 11.1 µM respectively, comparable to investigational xanthine oxidase inhibitors in early-stage research.
- **Anticancer and Antiproliferative Effects**: Molecular docking analysis of twelve metabolites from methanolic leaf extracts revealed six compounds with predicted anticancer activity exceeding 80%; rutin, quercetin, and luteolin achieved the highest docking scores (−12.39, −11.15, and −10.43 kcal/mol) against cancer-relevant targets, though in vitro MCF-7 breast cancer IC₅₀ values (282–459 mg/mL) suggest modest cytotoxicity at tested concentrations.
- **Nephroprotective Activity**: The combined polar phenolic constituents, including orientin (luteolin-8-C-glucoside) and isovitexin (apigenin-6-C-glucoside), are attributed to kidney-protective effects through suppression of oxidative stress and [inflammatory](/ingredients/condition/inflammation) mediators in renal tissue, as suggested by mechanistic phytochemical studies.

## Mechanism of Action

The principal mechanisms of Anastatica hierochuntica involve multi-target flavonoid activity: quercetin and luteolin donate hydrogen atoms to neutralize [reactive oxygen species](/ingredients/condition/antioxidant) and chelate transition metals that catalyze the Fenton reaction, reducing cellular oxidative burden. Anastatin A and B — structurally unique benzofuran-bearing flavonoids — appear to stabilize hepatocyte membranes and upregulate endogenous cytoprotective pathways, demonstrated by superior activity to silybin in hepatocyte protection assays. Rutin and quercetin competitively inhibit xanthine oxidase by occupying the enzyme's molybdopterin active site, reducing conversion of hypoxanthine to uric acid and concomitant superoxide generation. Additionally, β-sitosterol and campesterol contribute [anti-inflammatory](/ingredients/condition/inflammation) effects by competing with cholesterol for intestinal absorption and modulating NF-κB-related inflammatory signaling, while tannins and saponins exert [antimicrobial](/ingredients/condition/immune-support) effects through membrane disruption of bacterial cell walls.

## Clinical Summary

No human clinical trials investigating Anastatica hierochuntica have been identified in the published literature, representing a critical gap between traditional use and evidence-based validation. The most robust preclinical findings include [hepatoprotective](/ingredients/condition/detox) activity of anastatin A and B exceeding silybin in mouse hepatocytes, broad-spectrum antibacterial inhibition across three clinically relevant species, and xanthine oxidase inhibition by rutin and quercetin at low micromolar IC₅₀ concentrations. Antiproliferative activity in MCF-7 breast cancer cells was demonstrated but at high extract concentrations (IC₅₀ 282–459 mg/mL), limiting confidence in direct oncological application. Overall clinical confidence is low; current evidence supports mechanistic plausibility and traditional use rationale but cannot yet confirm therapeutic efficacy or safety in human populations.

## Nutritional Profile

Anastatica hierochuntica is not a food ingredient but a medicinal herb; its nutritional profile centers on pharmacologically active phytochemicals rather than macronutrient contribution. Flavonoids represent the dominant bioactive class, including rutin, quercetin, luteolin, apigenin-6-C-glucoside (isovitexin), luteolin-8-C-glucoside (orientin), anastatin A, and anastatin B. Sterols present include β-sitosterol and campesterol, which constitute a minor fraction of the lipophilic extract. Additional constituents include tannins, saponins, terpenoids, glycosides, anthraquinones, alkaloids, esters, thiols, and fatty acids distributed across leaf, stem, and seed fractions. Approximate concentrations of individual phytochemicals have not been published in quantified form for standardized plant material. Bioavailability of key flavonoids such as rutin and quercetin is expected to follow patterns established for these compounds in other plants — quercetin aglycone is more rapidly absorbed than rutin, which requires gut microbiota deglycosylation prior to absorption.

## Dosage & Preparation

- **Traditional Aqueous Decoction**: Dried whole plant or aerial parts boiled in water and consumed as a tea; historically prepared by soaking or simmering 5–10 g of dried material in 250 mL water; no standardized dose established.
- **Methanolic Extract (Research Grade)**: Used in phytochemical studies at varying concentrations; not available as a standardized commercial supplement form.
- **Aqueous Extract**: Demonstrated antiproliferative activity in MCF-7 cells at IC₅₀ of 282.50 mg/mL in vitro; clinical translation of this concentration is unknown.
- **Ethanol Extract**: Exhibited strongest [antioxidant](/ingredients/condition/antioxidant) IC₅₀ of 0.016 ± 0.001 mg/mL in DPPH assay; ethanol tinctures are used in some regional herbal preparations.
- **Dried Powder**: Traditionally used as a topical application or ingested; no validated therapeutic dose range exists for human supplementation.
- **Standardization**: No commercial standardization to specific flavonoid content (e.g., rutin, quercetin, anastatin A/B) has been established or validated.
- **Timing and Notes**: Traditional Middle Eastern use often involves preparation during religious observances; therapeutic timing recommendations are absent from scientific literature.

## Safety & Drug Interactions

Comprehensive human safety data for Anastatica hierochuntica are absent from the published scientific literature, and no toxicological studies with defined no-observed-adverse-effect levels (NOAELs) in humans have been identified. Traditional widespread use across Middle Eastern populations for centuries suggests a reasonable acute safety margin at customary decoction doses, but long-term safety, maximum tolerated doses, and organ-specific toxicity profiles remain uncharacterized. Given the xanthine oxidase-inhibitory activity of rutin and quercetin, theoretical caution is warranted in patients taking allopurinol or febuxostat, as additive uric acid-lowering effects could occur; similarly, the [antioxidant](/ingredients/condition/antioxidant) flavonoid load could potentially interact with chemotherapy agents whose efficacy depends on oxidative mechanisms. Pregnancy use should be approached with extreme caution: traditional use in labor induction suggests uterotonic or labor-stimulating properties that could be contraindicated during early pregnancy, and no safety data in lactating women are available.

## Scientific Research

The evidence base for Anastatica hierochuntica consists exclusively of in vitro cell-culture studies, phytochemical characterization, molecular docking computational analyses, and limited animal (murine) experiments — no human clinical trials have been published or identified in the available literature. Antibacterial inhibition zone assays, hepatocyte protection studies comparing anastatin A and B to silybin, and MCF-7 antiproliferative assays represent the strongest experimental data, though these lack the translational rigor of randomized controlled trials. Molecular docking studies provide mechanistic plausibility for anticancer and xanthine oxidase-inhibitory activity but are hypothesis-generating only, and IC₅₀ values for antiproliferative effects in MCF-7 cells (282–459 mg/mL) are pharmacologically high, raising questions about in vivo relevance. Substantial gaps remain in pharmacokinetic profiling, bioavailability data, dose-response characterization in animal models, and any human safety or efficacy data.

## Historical & Cultural Context

Anastatica hierochuntica holds deep cultural and spiritual significance across Islamic, Jewish, and Christian traditions in the Middle East and North Africa, where it is revered as a symbol of resurrection and rebirth due to its ability to rehydrate and expand dramatically from a desiccated, curled state when placed in water. In Islamic folk medicine, it is widely used during childbirth — the plant is soaked in water and the resulting infusion is given to women in labor, with the belief that as the plant 'opens,' so too will the delivery proceed smoothly; this use is documented across Egypt, Saudi Arabia, Jordan, and Palestine. In Jewish tradition it is associated with the biblical concept of resurrection and was historically believed to have traveled from the Holy Land, reinforcing its common name 'Rose of Jericho.' Ethnopharmacological surveys in the Arabian Peninsula and North Africa consistently record its use for diabetes management, wound healing, gastrointestinal complaints, and as a general tonic, anchoring contemporary phytochemical research in centuries of empirical use.

## Synergistic Combinations

Anastatica hierochuntica's rutin and quercetin content may synergize with vitamin C (ascorbic acid), which regenerates oxidized quercetin back to its active reduced form, prolonging [antioxidant activity](/ingredients/condition/antioxidant) — a well-characterized flavonoid-vitamin C interaction applicable to this plant's phenolic profile. For anti-hyperuricemic applications, combining the plant's xanthine oxidase-inhibitory flavonoids with tart cherry extract (which reduces uric acid via independent renal excretion pathways) may offer complementary multi-mechanism gout management. The [hepatoprotective](/ingredients/condition/detox) anastatin compounds may work additively with milk thistle (Silybum marianum) silybin, given that anastatin A and B demonstrated superior hepatocyte protection to silybin individually, suggesting potential for dose-sparing combination hepatoprotective formulations.

## Frequently Asked Questions

### What is Anastatica hierochuntica used for in traditional medicine?

In Middle Eastern and North African traditional medicine, Anastatica hierochuntica is used primarily for blood sugar regulation in diabetes, as a labor aid during childbirth, and for wound healing and gastrointestinal complaints. Ethnopharmacological surveys across Egypt, Saudi Arabia, Jordan, and Palestine consistently document these uses, with the plant prepared as a water decoction or infusion of dried aerial parts.

### What are the main active compounds in Rose of Jericho?

The primary bioactive compounds in Anastatica hierochuntica are flavonoids, including rutin, quercetin, luteolin, anastatin A, anastatin B, isovitexin (apigenin-6-C-glucoside), and orientin (luteolin-8-C-glucoside). Additional constituents include the sterols β-sitosterol and campesterol, plus tannins, saponins, terpenoids, and alkaloids distributed across leaf, stem, and seed fractions.

### Is there clinical trial evidence supporting Rose of Jericho health benefits?

No human clinical trials investigating Anastatica hierochuntica have been published to date; all available evidence comes from in vitro cell assays, molecular docking studies, and limited animal experiments. While preclinical findings — such as anastatin A and B surpassing silybin in hepatoprotection and rutin inhibiting xanthine oxidase at IC₅₀ 11.35 µM — are promising, clinical efficacy and safety in humans remain unestablished.

### Is Rose of Jericho safe to use during pregnancy?

Anastatica hierochuntica should be avoided during pregnancy, particularly in the first and second trimesters, because its traditional use specifically to stimulate and facilitate labor suggests uterotonic or labor-stimulating biological activity. No formal human safety or toxicology studies exist, and the absence of data combined with this traditional labor-induction use constitutes a significant contraindication during pregnancy.

### How does Anastatica hierochuntica inhibit xanthine oxidase and what does that mean for gout?

Rutin and quercetin — two major flavonoids in Anastatica hierochuntica — inhibit xanthine oxidase, the enzyme that converts hypoxanthine to uric acid, with IC₅₀ values of 11.35 µM and 11.1 µM respectively in in vitro assays. By blocking this enzyme, these compounds theoretically reduce uric acid production, which is the mechanism underlying gout pathology; however, no clinical trials have confirmed this effect translates to reduced serum uric acid or gout attacks in humans.

### What forms of Rose of Jericho are most effective for liver health benefits?

Methanolic extracts of Rose of Jericho have demonstrated the strongest hepatoprotective effects in research, with isolated compounds like anastatin A and B showing potency that exceeded the reference drug silybin in animal studies. Standardized extracts containing these benzofuran-moiety flavonoids may provide more consistent liver-protective benefits than whole plant preparations. However, most commercial supplements have not been standardized to these specific active compounds, so bioavailability and potency can vary significantly between products.

### Does Rose of Jericho interact with liver medications or drugs metabolized by the liver?

While Rose of Jericho demonstrates hepatoprotective properties, its potential to affect cytochrome P450 liver enzymes—which metabolize many medications—has not been thoroughly studied in humans. Individuals taking pharmaceutical medications metabolized by the liver, such as statins, warfarin, or immunosuppressants, should consult a healthcare provider before supplementing with Rose of Jericho. The herb's potent biological activity suggests caution is warranted until more safety interaction data becomes available.

### Who would benefit most from Rose of Jericho supplementation based on current research?

Individuals concerned about liver health, those with metabolic conditions like gout (due to xanthine oxidase inhibition), or those seeking antioxidant support may be candidates for Rose of Jericho supplementation based on available evidence. People with established liver disease or those taking hepatically metabolized medications should work with a healthcare provider to determine appropriateness. Research is still limited in human populations, so benefits are best supported in traditional medicine contexts and preliminary laboratory studies rather than large-scale clinical trials.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*